Randa Mohamed Abdel-Moneim El-Mofty*

Professor of Ophthalmology, Kasr Al-Ainy, Cairo University, Cairo, Egypt

*Corresponding Author: Randa Mohamed Abdel-Moneim El-Mofty, Professor of Ophthalmology, Kasr Al-Ainy, Cairo University, Cairo, Egypt.

Received: February 26, 2025; Published: April 01, 2025

Abstract

Inherited retinal dystrophies (IRD) have been always a challenge for everyone including the patients, the families and the ophthalmologists. Early diagnosis has aided early rehabilitation of the patients but still with no definite cure. However, the field of ophthalmology is now undergoing a notable transformation, due to the advancements in gene therapy that can hold the light at the end of the “dark” tunnel. As we stand at the crossroads of scientific innovation and clinical application, the potential for restoration of vision is more perceptible than ever.

References

Citation

Citation: Randa Mohamed Abdel-Moneim El-Mofty. “The Evolution of Gene Therapy in Ophthalmology – What Can the Future Hold?".Acta Scientific Ophthalmology 8.5 (2025): 01.

Copyright

Copyright: © 2025 Randa Mohamed Abdel-Moneim El-Mofty. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.